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ABSTRACT : The effect of thymectomy on myasthenia gravis was evaluated in 
the 48 patients with thymectomy for myasthenia gravis in the First Department of 
Surgery, Nagasaki University School of Medicine. 
   The surgical approaches were done by midsternotomy in 44, by right thoractomy 
in 3 and by transcervical route in 1 respectively. As a rule, extended thymectomy 
was mainly applied. The disease stages in most cases included the types of Osserman 
II b and/or II a. 
   The effect of thymectomy on myasthenia gravis was compared between the 
patients with and without thymoma. The effect of thymectomy for patients without 
thymoma was superior to that for patients with thymoma. There was no close 
relationship between the suffering time and the effect of thymectomy. Interestingly 
enough, the surgical outcome for those who had moderate or severe formation of 
germinal center in the resected thymic glands was not satisfactory and some 
aggravated following thymectomy.
       INTRODUCTION 
 Advances in thoracic surgery made it posAi-
ble to perform thymectomy with safety in 
wide clinical use. Thymectomy is now the main 
therapeutic tool of choice for myasthenia 
gravis in accordance with ensurance of post-
operative respiratory care. Thymectomy is at 
first selected for the treatment of myasthenia 
gravis. In this study, the results of thy-
mectomy for myasthenia gravis were evaluated 
on the basis of clinical experience.
         CASES 
The 48 patients with thymectomy for myas-
thenia gravis were subjected to this study dur-
ing a period from January 1965 to December 
1987 in the First Department of Surgery, 
Nagasaki University School of Medicine. 
According to the distribution of sex in this 
group, females were predominant in a ratio of 
33 to 15. The most predominant age was in the 
4th decade, next was 2nd and 3rd decade as 
shown in Table 1. 
 The symptoms were classified by Ossermann 
classification as shown in Table 2. Most were 
Ossermann fib and Ila and a very few included 
the types of Ossermann I and III. Thirteen 
patients had thymoma and the others had 
non-thymoma. The suffering duration ranged 
from 2 years to 4 years in most cases, and the 
next was from 1 year to 2 years, followed by
            Table 1. Patients 
AGE MALE FEMALE TOTAL 
  -19 1 1 
20^- 6 5 11 
30- 1 10 11 
40- 6 12 18 
50- 1 2 3 
60- 2 2 
70- 1 1 2 
       15 (37.6) 33 (39.6) 48 (38.9)
Table 2. Disease stage classification Osserman 
        classification 
Osserman type Male Female Total 
     I 4 1 5 
    II a 8 12 20
    Il b 2 19 21 
    III 1 1 2 
              15 33 48
the duration less than 1 year and more than 8 
years as shown in Fig. 1. 
 The surgical approaches comprised of mid-
sternotomy in 44, right thoracotomy in 5 
including combined resection with the lung in 2 
and transcervical route in 1. 
 The effect of thymectomy on myasthenia
gravis was regarded as improvement in 53.8% 
of thymoma patients and 6 5. 7 % in non-
thymoma as shown in Table 3. In the relation-
ship between surgical effect and suffering 
duration, the effect of thymectomy was promi-
nent in patients with the suffering duration 
ranged from 6 months to 3 years. However, 
aggravated patients who experienced the same 
suffering duration, demonstrated a result of 
various surgical outcome. In patients with 
shorter or longer suffering time, the surgical 
outcome was nearly unchanged. Meanwhile, in 
patients with aggravated symptoms following 
thymectomy, pronounced formation of 
germinal center in the resected thymic glands 
was seen. The degree of formation of germinal 
center proportionated to the survival time and 
alleviation of patients' suffering as shown in 
Table 4.
Table 4. Relationship between effect of thy-
        mectomy and germinal center 
                     germinal center 
              no slight moderate severe 
complete 5 3 1 1 
remission 
improvement 25 18 5 2 
no change 14 4 4 6 
aggravation 4 4
Fig. 1. Efficacy of thymectomy for myasthenia Gravis in relation to suffering 
       period
           Table 3. Efficacy of thymectomy for myasthenia gravis 
                    with thmoma without thymoma total 
complete r mission 1 4] 5 
improvement 6(53.8%) 1(62.7%) 25(62.5%) 
no change 3 11 . 14 
aggravation 3 1 4
 The surgical outcome was consistent with 
the degree of germinal center. The more the 
degree of formation of germinal center 
increases, the more surgical outcome becomes 
detrimental. Most of those in whom germinal 
centers were severe in resected specimens show-
ed a result of no change following thymectomy 
and/or aggravated postoperative courses.
        DISCUSSION 
 Since BLALOCK 1) reported 2 successful cases 
treated with thymectomy for myasthenia 
gravis, it has been focused on thymectomy. In 
Japan, thymectomy has been prevalent since 
1960. However, myasthenia gravis is still 
dubious in its pathogenesis. 
 In 1970, the transcervical approach for thy-
mectomy has become common in the United 
states of America. The reasons for common 
application of thymectomy were that it had 
less postoperative complication, good cosmotic 
wound healing, and easy respiratory support. 
 However, it was defined that surgical out-
come of thymectomy via transcervical approach 
was inferior to that via midsternotomy. At 
present extended thymectomy including a 
resection of the surrounding fatty tissues is 
recommended for myasthenia gravis 2 ). Palli-
ation after thymectomy in thymoma patients 
was obtained in 20 %. On the other hand, in 
non-thymoma patients, muscular weakness 
after thymectomy was gradually improved 
and it rose to 50% at 5 years showing delayed 
remission. Meanwhile, effectiveness of thy-
mectomy was 80% at 3 months, 90% at 1 year 
in non-thymoma patients although it was 70% 
at 3 months, demonstrating relatively satis-
factory result in the early stage of thymoma 
patients 3) 
. 
 These showed the superiority of the results 
to medical treatments9). Even if medical treat-
ments are required after thymectomy, the 
dosis of drugs makes it possible to reduce sign-
ificantly. 
 In terms of patient's age, it is well known 
that the indication for thymectomy is to be 
limited to patients of less than 40 years old, 
and even in childhood thymectomy is of great 
benefit in improving symptoms of myasthenia
without functional defect of the thymic gland 6~ 
There was no definitive difference in surgical 
outcome after thymectomy between different 
ages. In this series the old patients of maximum 
age of 72 years showed an improvement under 
less dosis of maintenance drugs. It is accepted 
that the shorter the suffering time from 
myasthenia, the better the surgical outcome 
ensures. However, in this series the duration of 
suffering were not necessarily implicating. It 
is well known that the severity of histologic 
generation of germinal centers influences the 
effect of thymectomy for myasthenia gravis. 
The results of this study was consistant with 
this concept. 
 It is accepted that the degree of generation 
of germinal centers proportionates to the 
duration of suffering time. Therefore surgical 
outcome may be influenced by the degree of 
generation of germinal centers as well as the 
duration of suffering time. 
 The germinal center is composed of B cells, 
and the thymic gland plays a role in defferent-
iating premature cells as well as in generating 
antiacetylcholine receptor antibody (anti-Ach 
RAb ). However, as its activity is very weak, 
so the effect of thymectomy is not valid. Fur-
thermore, it is said that anti-AchRAb is 
generated at the site of peripheral lymphoid 
tissues. It is believed that the thymic gland 
plays a role in leading to myasthenic abnor-
mality. The pathogenesis is very complex in 
relation to functional ablation of the 
parathymic glands which has identical origin 
in the genesis 
 In conclusion, thymectomy is effective in 
improving myasthenia gravis and thymectomy 
of choice should be first recommended.
